secwatch.observer — SEC 8-K summary
======================================

Issuer:     Gossamer Bio, Inc. (GOSS)
CIK:        0001728117
Form:       8-K
Filed at:   2024-05-24T23:59:59+00:00
Accession:  0001728117-24-000059
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Gossamer Bio receives Nasdaq minimum bid deficiency; cure period to Nov 18, 2024
--------------------------------------------------------------------------------

- Nasdaq notice on May 22, 2024; stock below $1.00 for 30 consecutive business days through May 21.
- Company has 180 calendar days, until November 18, 2024, to regain compliance.
- To cure, closing bid must be at least $1.00 for ten consecutive business days.
- If not cured, may transfer to Nasdaq Capital Market for additional 180 days or face delisting.
- Company may consider a reverse stock split to address the deficiency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1728117/000172811724000059/0001728117-24-000059-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1728117/000172811724000059/goss-20240522.htm
  HTML page:      https://secwatch.observer/filing/0001728117-24-000059

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer